Management of clinical T2N0 esophageal cancer: a review
| dc.contributor.author | Vining, Patrick | |
| dc.contributor.author | Birdas, Thomas J. | |
| dc.contributor.department | Surgery, School of Medicine | en_US |
| dc.date.accessioned | 2020-01-02T13:10:33Z | |
| dc.date.available | 2020-01-02T13:10:33Z | |
| dc.date.issued | 2019-08-11 | |
| dc.description.abstract | While management of locally advanced esophageal cancer has mostly involved multimodality therapy, management of clinical T2N0 patients has been more controversial, primarily as a result of inaccurate clinical staging with existing modalities. This review article examines current literature on this topic and provides recommendations for management of individual patients. | en_US |
| dc.identifier.citation | Vining, P., & Birdas, T. J. (2019). Management of clinical T2N0 esophageal cancer: a review. Journal of thoracic disease, 11(Suppl 12), S1629–S1632. doi:10.21037/jtd.2019.07.85 | en_US |
| dc.identifier.uri | https://hdl.handle.net/1805/21669 | |
| dc.language.iso | en_US | en_US |
| dc.publisher | AME Publishing Company | en_US |
| dc.relation.isversionof | 10.21037/jtd.2019.07.85 | en_US |
| dc.relation.journal | Journal of Thoracic Disease | en_US |
| dc.rights | Publisher Policy | en_US |
| dc.source | PMC | en_US |
| dc.subject | Esophageal cancer | en_US |
| dc.subject | Esophagectomy | en_US |
| dc.subject | Neoadjuvant therapy | en_US |
| dc.title | Management of clinical T2N0 esophageal cancer: a review | en_US |
| dc.type | Article | en_US |